OPDIVO-1*


Brand:
OPDIVO-1*

Manufacturer:
BRISTOL-MEYER-SQUBB INC

  
List of Drugs:
  • Nivolumab- Opdivo -@-(Dec 2014) -Anti-cancer

Compositions:
Nivolumab- mg,
  
List of Related Indications:
  • Treatment of Patients with Unresectable or Metastatic Melanoma and disease progression following Ipilmumab and, if BRAF V600 Mutation Positive,a BRAF Inhibitor

Strength Rate Packing Style
mg 0.00 unit